Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury
- First Posted Date
- 2020-11-18
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT04633889
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Novel Assessment of Synaptic Density in Progressive MS
Early Phase 1
- Conditions
- Relapsing Multiple SclerosisMultiple SclerosisPrimary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
- Interventions
- First Posted Date
- 2020-11-18
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04634994
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients
Early Phase 1
Completed
- Conditions
- Multiple System Atrophy (MSA) With Orthostatic HypotensionMultiple System AtrophyMultiple System Atrophy, Cerebellar VariantMultiple System Atrophy, Parkinson Variant (Disorder)
- Interventions
- Drug: [F-18]PBR06
- First Posted Date
- 2020-11-05
- Last Posted Date
- 2022-08-19
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT04616456
- Locations
- 🇺🇸
Movement Disorders Clinic, 60 Fenwood Road, Boston, Massachusetts, United States
Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing
- First Posted Date
- 2020-11-02
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 53
- Registration Number
- NCT04611750
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇦🇺Monash University, Clayton, Victoria, Australia
Pilot Study of Financial Incentives for YMSM for HIV Testing and PrEP
Not Applicable
- Conditions
- HIV
- Interventions
- Behavioral: Incentives
- First Posted Date
- 2020-10-30
- Last Posted Date
- 2020-10-30
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04609995
Lipid Management in Renal Transplant Recipients Using Evolocumab.
Phase 4
Recruiting
- Conditions
- Hyperlipidemias
- Interventions
- Drug: Statins (Cardiovascular Agents)
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT04608474
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
EMG Biofeedback Treatment for Chronic Low Back Pain, Cancer Pain and Migraines
Not Applicable
Recruiting
- Conditions
- MigraineMastectomyLumpectomyChronic Low-back Pain
- Interventions
- Device: JOGO Digital Therapeutics EMG Biofeedback for Persistent Post Mastectomy PainDevice: JOGO Digital Therapeutics EMG Biofeedback for Lower Back PainDevice: JOGO Digital Therapeutics EMG Biofeedback for Migraine
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 330
- Registration Number
- NCT04607460
- Locations
- 🇺🇸
Brigham and Women's Hospital, Chestnut Hill, Massachusetts, United States
Symptom-specific TMS Targets for Depression and Anxiety
Phase 2
Completed
- Conditions
- AnxietyDepressionMajor Depressive Disorder
- Interventions
- Procedure: Transcranial magnetic stimulation
- First Posted Date
- 2020-10-27
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04604210
- Locations
- 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
Personalizing Intervention to Reduce Clinical Inertia in the Treatment of Hypertension
Not Applicable
Completed
- Conditions
- Hypertension
- Interventions
- Behavioral: Pharmacist E-DetailingBehavioral: Audit and Feedback
- First Posted Date
- 2020-10-27
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 511
- Registration Number
- NCT04603560
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy
Recruiting
- Conditions
- Neonatal Encephalopathy
- First Posted Date
- 2020-10-27
- Last Posted Date
- 2023-08-09
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04603547
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath